• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

海藻酸钙凝胶作为血管内动脉瘤栓塞体内生物相容性材料的初步研究。

Preliminary investigation of calcium alginate gel as a biocompatible material for endovascular aneurysm embolization in vivo.

作者信息

Becker Timothy A, Preul Mark C, Bichard William D, Kipke Daryl R, McDougall Cameron G

机构信息

Neural Engineering Laboratory, Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan, USA.

出版信息

Neurosurgery. 2007 Jun;60(6):1119-27; discussion 1127-8. doi: 10.1227/01.NEU.0000255447.90106.12.

DOI:10.1227/01.NEU.0000255447.90106.12
PMID:17538387
Abstract

OBJECTIVE

We sought to expand our assessment of calcium alginate as an embolic agent in an aneurysm model in swine that survived from 30 to 90 days. The objective of this study was to assess the biocompatibility and stability of calcium alginate in aneurysms in vivo.

METHODS

Ten models were created from a venous pouch sutured to the carotid artery, simulating flow to a side-wall aneurysm. Eight swine received complete embolizations, and two were less than 50% embolized to be used as controls. Alginate and calcium chloride were injected from concentric-tube microcatheters to form a mass that filled the aneurysm pouch.

RESULTS

Angiography and histology verified complete aneurysm occlusion and neck healing up to 90 days in eight swine. Both control animal aneurysms ruptured within 8 days. No animals showed evidence of downstream calcium alginate gel propagation. A minor bioactive response to the alginate gel was noted at 30 days, and fibrous tissue grew over the aneurysm orifice, sealing off the defect. No degenerative or inflammatory response was observed. At 90 days, moderate fibrous tissue surrounded the alginate. Tissue growth across the aneurysm neck remained complete and stable with no signs of neointimal growth into the parent vessel.

CONCLUSION

Calcium alginate was an effective endovascular occlusion material that filled the aneurysm and provided an effective template for tissue growth across the aneurysm neck after 30 days and up to 90 days. Complete filling of the aneurysm with calcium alginate ensures stability, biocompatibility, and optimal healing for up to 90 days in swine.

摘要

目的

我们试图在存活30至90天的猪动脉瘤模型中扩大对海藻酸钙作为栓塞剂的评估。本研究的目的是评估海藻酸钙在体内动脉瘤中的生物相容性和稳定性。

方法

通过将静脉囊缝合到颈动脉上创建10个模型,模拟侧壁动脉瘤的血流。8只猪接受了完全栓塞,2只栓塞少于50%作为对照。从同心管微导管注射海藻酸盐和氯化钙,形成填充动脉瘤囊的团块。

结果

血管造影和组织学证实8只猪的动脉瘤完全闭塞且颈部愈合长达90天。两只对照动物的动脉瘤在8天内破裂。没有动物显示出海藻酸钙凝胶向远端传播的迹象。在30天时观察到对海藻酸钙凝胶有轻微的生物活性反应,纤维组织在动脉瘤口生长,封闭了缺损。未观察到退行性或炎症反应。在90天时,海藻酸钙周围有中等程度的纤维组织。动脉瘤颈部的组织生长保持完整和稳定,没有新生内膜长入母血管的迹象。

结论

海藻酸钙是一种有效的血管内闭塞材料,可填充动脉瘤,并在30天至90天内为动脉瘤颈部的组织生长提供有效的模板。在猪体内,用海藻酸钙完全填充动脉瘤可确保长达90天的稳定性、生物相容性和最佳愈合。

相似文献

1
Preliminary investigation of calcium alginate gel as a biocompatible material for endovascular aneurysm embolization in vivo.海藻酸钙凝胶作为血管内动脉瘤栓塞体内生物相容性材料的初步研究。
Neurosurgery. 2007 Jun;60(6):1119-27; discussion 1127-8. doi: 10.1227/01.NEU.0000255447.90106.12.
2
Calcium alginate gel as a biocompatible material for endovascular arteriovenous malformation embolization: six-month results in an animal model.海藻酸钙凝胶作为一种用于血管内动静脉畸形栓塞的生物相容性材料:动物模型的六个月结果
Neurosurgery. 2005 Apr;56(4):793-801; discussion 793-801. doi: 10.1227/01.neu.0000156494.94675.bb.
3
In vivo assessment of calcium alginate gel for endovascular embolization of a cerebral arteriovenous malformation model using the Swine rete mirabile.使用猪奇静脉网对海藻酸钙凝胶用于脑动静脉畸形模型血管内栓塞的体内评估。
Neurosurgery. 2002 Aug;51(2):453-8; discussion 458-9.
4
Calcium alginate provides a high degree of embolization in aneurysm models: a specific comparison to coil packing.海藻酸钙在动脉瘤模型中提供高度栓塞:与弹簧圈填塞的具体比较。
Neurosurgery. 2004 Dec;55(6):1401-9; discussion 1409. doi: 10.1227/01.neu.0000143616.22174.67.
5
Alginate for endovascular treatment of aneurysms and local growth factor delivery.用于动脉瘤血管内治疗和局部生长因子递送的藻酸盐。
AJNR Am J Neuroradiol. 2003 Jun-Jul;24(6):1214-21.
6
In vivo experimental aneurysm embolization in a swine model with a liquid-to-solid gelling polymer system: initial biocompatibility and delivery strategy analysis.在猪模型中使用液体到固体胶凝聚合物系统进行体内实验性动脉瘤栓塞:初步的生物相容性和输送策略分析。
World Neurosurg. 2012 Nov;78(5):469-80. doi: 10.1016/j.wneu.2011.10.029. Epub 2011 Nov 1.
7
Assessment of EmboGel--a selectively dissolvable radiopaque hydrogel for embolic applications.评估 EmboGel--一种用于栓塞应用的选择性可溶解的不透射线水凝胶。
J Vasc Interv Radiol. 2011 Feb;22(2):203-11. doi: 10.1016/j.jvir.2010.10.010. Epub 2010 Dec 23.
8
Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine.冠状动脉内注射原位形成的海藻酸盐水凝胶可逆转猪心肌梗死后的左心室重构。
J Am Coll Cardiol. 2009 Sep 8;54(11):1014-23. doi: 10.1016/j.jacc.2009.06.010.
9
Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat.注射用藻酸盐植入物对大鼠近期和陈旧性心肌梗死后心脏重塑及功能的影响。
Circulation. 2008 Mar 18;117(11):1388-96. doi: 10.1161/CIRCULATIONAHA.107.727420. Epub 2008 Mar 3.
10
Calcium alginate gel: a biocompatible and mechanically stable polymer for endovascular embolization.海藻酸钙凝胶:一种用于血管内栓塞的生物相容性且机械稳定的聚合物。
J Biomed Mater Res. 2001 Jan;54(1):76-86. doi: 10.1002/1097-4636(200101)54:1<76::aid-jbm9>3.0.co;2-v.

引用本文的文献

1
Liquid Embolic Agents for Endovascular Embolization: A Review.用于血管内栓塞的液体栓塞剂:综述
Gels. 2023 May 4;9(5):378. doi: 10.3390/gels9050378.
2
Evaluation of the safety and efficacy of transarterial sevelamer embolization in a rabbit liver cancer model: A challenge on the size rule for vascular occlusion.兔肝癌模型中经动脉司维拉姆栓塞术的安全性和有效性评估:对血管闭塞大小规则的挑战
Front Bioeng Biotechnol. 2022 Dec 12;10:1058042. doi: 10.3389/fbioe.2022.1058042. eCollection 2022.
3
A feasibility study using sodium alginate injection for penetrating abdominal trauma in a swine model.
应用海藻酸钠注射液治疗猪腹部穿透性创伤的可行性研究。
Sci Rep. 2022 Oct 12;12(1):17132. doi: 10.1038/s41598-022-22186-0.
4
Emerging Embolic Agents in Endovascular Embolization: An Overview.血管内栓塞术中新兴的栓塞剂:综述
Prog Biomed Eng (Bristol). 2020 Jan;2(1). doi: 10.1088/2516-1091/ab6c7d. Epub 2020 Feb 12.
5
Application of a rabbit-elastase aneurysm model for preliminary histology assessment of the PPODA-QT liquid embolic.兔弹性蛋白酶动脉瘤模型在PPODA-QT液体栓塞剂初步组织学评估中的应用
Surg Neurol Int. 2021 Jul 6;12:330. doi: 10.25259/SNI_163_2021. eCollection 2021.
6
Preclinical extracranial aneurysm models for the study and treatment of brain aneurysms: A systematic review.用于研究和治疗脑动脉瘤的临床前颅内动脉瘤模型:系统评价。
J Cereb Blood Flow Metab. 2020 May;40(5):922-938. doi: 10.1177/0271678X20908363. Epub 2020 Mar 3.
7
Saccular Aneurysm Models Featuring Growth and Rupture: A Systematic Review.具有生长和破裂特征的囊状动脉瘤模型:一项系统综述。
Brain Sci. 2020 Feb 13;10(2):101. doi: 10.3390/brainsci10020101.
8
Advances in Biomaterials and Technologies for Vascular Embolization.生物材料和血管栓塞技术的进展。
Adv Mater. 2019 Aug;31(33):e1901071. doi: 10.1002/adma.201901071. Epub 2019 Jun 6.
9
Recurrence of endovascularly and microsurgically treated intracranial aneurysms-review of the putative role of aneurysm wall biology.血管内治疗和显微手术治疗的颅内动脉瘤复发——动脉瘤壁生物学假定作用的综述
Neurosurg Rev. 2019 Mar;42(1):49-58. doi: 10.1007/s10143-017-0892-2. Epub 2017 Aug 17.
10
Biocompatibility and Effectiveness Evaluation of a New Hemostatic Embolization Agent: Thrombin Loaded Alginate Calcium Microsphere.一种新型止血栓塞剂:载凝血酶海藻酸钙微球的生物相容性及有效性评估
Biomed Res Int. 2017;2017:1875258. doi: 10.1155/2017/1875258. Epub 2017 Feb 16.